Healthcare provider profile · identity verified

Mark D Lenderman, MD

Family Practice · ASHEVILLE, NC · NPI 1508827874

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	653	172
Amlodipine Besylate	Amlodipine Besylate	406	115
Omeprazole	Omeprazole	268	78
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	267	71
Losartan Potassium	Losartan Potassium	266	72
Levothyroxine Sodium	Levothyroxine Sodium	258	64
Lisinopril	Lisinopril	256	70
Gabapentin	Gabapentin	224	62
Simvastatin	Simvastatin	213	58
Metoprolol Succinate	Metoprolol Succinate	179	55
Tramadol Hcl	Tramadol Hcl	171	31
Hydrochlorothiazide	Hydrochlorothiazide	157	52
Eliquis	Apixaban	137	32
Tamsulosin Hcl	Tamsulosin Hcl	137	38
Metformin Hcl Er	Metformin Hcl	136	42
Rosuvastatin Calcium	Rosuvastatin Calcium	135	40
Trazodone Hcl	Trazodone Hcl	122	38
Allopurinol	Allopurinol	116	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	115	33
Escitalopram Oxalate	Escitalopram Oxalate	110	34
Bupropion Xl	Bupropion Hcl	101	27
Prednisone	Prednisone	92	63
Ozempic	Semaglutide	90	15
Potassium Chloride	Potassium Chloride	88	27
Metformin Hcl	Metformin Hcl	86	24
Sertraline Hcl	Sertraline Hcl	86	20
Duloxetine Hcl	Duloxetine Hcl	84	22
Clonazepam	Clonazepam	81	16
Fluticasone Propionate	Fluticasone Propionate	80	25
Alprazolam	Alprazolam	76	24
Xarelto	Rivaroxaban	76	12
Citalopram Hbr	Citalopram Hydrobromide	72	16
Albuterol Sulfate Hfa	Albuterol Sulfate	70	28
Metoprolol Tartrate	Metoprolol Tartrate	69	21
Meloxicam	Meloxicam	66	19
Alendronate Sodium	Alendronate Sodium	65	22
Jardiance	Empagliflozin	63	11
Lorazepam	Lorazepam	53	14
Pantoprazole Sodium	Pantoprazole Sodium	53	17
Montelukast Sodium	Montelukast Sodium	49	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	20
Famotidine	Famotidine	45	16
Spironolactone	Spironolactone	45	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	14
Warfarin Sodium	Warfarin Sodium	44	11
Carvedilol	Carvedilol	43	15
Mounjaro	Tirzepatide	43	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	40	40
Ondansetron Hcl	Ondansetron Hcl	39	12
Glimepiride	Glimepiride	38	13
Synthroid	Levothyroxine Sodium	38	14
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Furosemide	Furosemide	35	16
Shingrix	Varicella-Zoster Ge/As01b/Pf	33	30
Mirtazapine	Mirtazapine	29	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	28	28
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	16
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Finasteride	Finasteride	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Amoxicillin	Amoxicillin	25	23
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Nitroglycerin	Nitroglycerin	22	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Cephalexin	Cephalexin	21	18
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Azithromycin	Azithromycin	19	18
Buspirone Hcl	Buspirone Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Atenolol	Atenolol	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	11
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Zenpep	Lipase/Protease/Amylase	12	suppressed
Clobazam	Clobazam	11	suppressed
Estradiol	Estradiol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Primidone	Primidone	11	suppressed
Rufinamide	Rufinamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error